Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies
Dendritic cell (DC) vaccination has been investigated as a potential strategy to target hematologic malignancies, while generating sustained immunological responses to control potential future relapse.Nonetheless, few clinical trials have shown robust long-term efficacy.It has been suggested that a combination of surmountable shortcomings, Machine